Global Immunodiagnostics Market is Growing at a CAGR of 7.80% in 2026

Global immunodiagnostics market is expected to rise from to an estimated value of USD 24.89 billion by 2026 registering a substantial CAGR of 7.80% in the forecast period of 2019-2026. This rise in the market can be attributed to rising prevalence of chronic diseases and technological advancements.

Immunodiagnostics is a diagnostic method that uses antigen-antibody reactions to measure the presence of molecules in biological fluids. It is used primarily for detecting and diagnosing infectious diseases, chronic diseases (cancer, cardiovascular diseases), autoimmune disease, hormonal disorder etc. These tests are also used to distinguish between compatible blood types. They provide precise, quick and accurate results and hence are gaining importance.

Get Exclusive Sample Report: @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-immunodiagnostics-market

Competitive Analysis: Global Immunodiagnostics Market

Global immunodiagnostics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of immunodiagnostics market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors: Global Immunodiagnostics Market

Few of the major market competitors currently working in the immunodiagnostics market are Abbott., F. Hoffmann-La Roche Ltd, Danaher., Adaptive Biotechnologies., QIAGEN, AMARANTUS BIOSCIENCE HOLDINGS, INC., AESKU.GROUP GmbH & Co. KG, Avant Diagnostics, Inc., bioMérieux SA, Inova Diagnostics, Inc., OraSure Technologies, Myriad Genetics, Inc, Omega Diagnostics Group PLC, Nexus-Dx, Protagen, Quest Diagnostics Incorporated., Seramun Diagnostica GmbH., SQI Diagnostics, Tecan Trading AG, Siemens Healthcare GmbH, DiaSorin, Erba Diagnostics, Svar Life Science and Exagen Inc. amongst others.

Segmentation: Global Immunodiagnostics Market

• By Product (Reagents, Instruments, Software & Services)
• By Technology (ELISA, CLIA, RIA, FIA, Rapid Test, Others)
• By End User (Clinical Laboratories, Hospitals, Academic & Research Centers, Pharmaceutical & Biotechnology Industry, Diagnostic Centers, Others)
• By Application (Oncology & Endocrinology, Hepatitis & Retrovirus Testing, Infectious Disease Testing, GI Stool Testing, Autoimmune Disorders, Bone & Mineral Diseases, Cardiac Biomarkers, Others)
• By Type (Immunodiagnostic Instruments, Immunoassays)
• By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)

Market Drivers

• Growing ageing & geriatric population would also boost the growth of this market as they are more prone to chronic and infectious diseases
• Rising need for correct, error free and speedy diagnostic tests
• Growing awareness regarding the benefits of immunodiagnostics drives the growth of this market
• Rising adoption of point of care testing (POCT) drives the demand for this market
• Rising volumes of test due to the integration of laboratories would boost the growth of this market

Market Restraints

• Stringent regulations imposed by the government hinder the growth of this market
• Cost of immunodiagnostics being expensive restrains its growth

Reasons to Purchase this Report

• Current and future of global immunodiagnostics market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
• Regions/Countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

• All segmentation provided above in this report is represented at country level
• All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches.